One man's rare Alzheimer’s mutation delayed its onset
nature.com
nature.com
I carry four (as far as I know) rare and low frequency homozygous minor allele SNPs in RELN:
rs39335(G;G)
rs3914132(C;C)
rs7696175(C;C)
rs4298437(T;T)
And guess what? I have Bipolar Disorder Schizoaffective type and my therapists keep telling me I have Aspergers.
This gene seems to bind to zinc, and a deficiency of zinc is also found in Alzheimer's.
https://www.jneurosci.org/content/41/13/3025#:~:text=Inflamm....
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010690/
https://alzres.biomedcentral.com/articles/10.1186/s13195-021...
Zinc has helped me in many ways.
Since the mutation is a GAIN OF FUNCTION mutation, more zinc means less risk of Alzheimer's.
Found it by going to the list of all alleles of that gene (https://ensembl.org/Homo_sapiens/Transcript/Variation_Transc...) and looking for one that changes the 3444th amino acid from an H to an R
I take zinc sulfate. 220 mg with 50mg of elemental zinc.
(Those are: tingling in fingers, vivid dreams, and especially bad nausea and stomach pain. Also higher testosterone and dramatically higher sex drive, though maybe you like that.)
But the side effects from the zinc could be from a deficiency as well.
If you are low in serotonin and dopamine and take zinc, it will increase these, and since you were low for so long, the reaction to higher levels will be more pronounced. The increase in serotonin is usually what causes stomach upset, and diarrhea.
So it’s probably better for people who haven’t taken zinc who are deficient to start slowly.
https://www.nature.com/articles/s41598-021-94124-5
B6 increases dopamine so that might play a role as well.
Does he, like, tell them? Do they tell people they're dating? It's not clear how this perpetuates.
Found it! The ethical question isn't in the transcript as far as I can see, maybe my memory deceived me - https://www.npr.org/2020/03/23/820009335/invisibilia-an-unli...
My wife and I smell different scents with differing sensitivities, so I can believe it. (I still remember the smell of roaches from when I was a young child.)
https://www.npr.org/sections/health-shots/2020/03/23/8202745...
But then one day, about 10 years into the marriage, when Les was 31, he came home, and strangely, Joy says, he smelled different. "His lovely male musk smell had got this overpowering sort of nasty yeast smell," she says.
https://pubs.acs.org/doi/10.1021/acscentsci.2c01468
https://www.smh.com.au/national/nsw/how-smelly-t-shirts-and-...
This is interesting by itself. It suggests that part of the onset of Parkinson's involves a large, rapid change taking place somewhere.
So possible that process begins suddenly. Whatever the cause you’re right that is quite interesting
> She told BBC Scotland that not knowing Les had Parkinson's put her family in a "negative spiral".
> "What if we did know?," she said
> "It would have changed things dramatically.
The Spanish speaking podcast Radio Ambulante covered the story few years ago. Here’s an English transcription of it https://radioambulante.org/en/transcripcion/the-paisa-mutati...
I would want to know.
Also excited to see how LLM's and DL/AI can help accelerate research by reducing menial tasks for researchers and scientists as well as by contributing to drug discovery. https://medicalxpress.com/news/2023-05-scientists-ai-drug-al...
Plasma Proteome of Long-covid Patients Indicates Hypoxia-mediated Vasculo-proliferative Disease With Impact on Brain and Heart Function (Preprint)
https://assets.researchsquare.com/files/rs-2448315/v1/8043bd...
An excerpt:
> In Fig. 7A, hierarchical clustering heatmaps reflect the levels of neurological markers across the patient groups (markers have been curated by OLINK). The values of the PEA expression levels were hierarchically clustered based on Pearson correlation algorithms. Markers selected through the above methodology were investigated for functional annotation using tools from the GSEA platform and MSigDB data positories (Fig. 7B). This latest analysis demonstrated that functional clusters were formed around leukocyte migration, positive immune signals, glial cell differentiation, neurogenesis and MAPK regulatory modules. Taken together, these pathways predict a possible brain-blood barrier dysfunctionality grounded on cell proliferation. Graphs in Fig. 7C illustrate the expression levels of individual markers from the functional groups presented in Fig. 7B. One of the highly expressed markers, was the amyloid precursor protein (APP; Supplementary Fig. 10) which is known to be a pathognomonic marker for both Alzheimer disease and brain inflammation [61–65]. Additional markers for brain dysfunction include JAM2 (endothelial tight junctions protein), SNAPIN (a mediator of neuronal autophagy-lysosomal function in developing neurons), KCNH2 (potassium channel), S100A14 (involved in cell motility adhesion and growth), KIAA0319 (language impairment biomarker), and IROR1 (a receptor tyrosine kinase like orphan receptor 1, which regulates neurites growth in the central nervous system having also WNT-signaling pathway functions, and being crucial for the auditive apparatus maintenance).
But I see there are side effects as well (Thanks for pointing it out) -https://www.axios.com/2023/05/15/alzheimers-drugs-patients-r... -https://www.science.org/content/article/scientists-tie-third...
It's good then that we now have another solution to tackle this like mentioned in OP, such as targeting reelin or APOE. And if anti-amyloids, or reducing amyloids are only a part solution. Hopefully, the findings keep continuing to cure Alzheimers.
[1]: https://www.npr.org/2021/06/07/1003964235/fda-approves-contr... [2]: https://www.nbcnews.com/science/science-news/alzheimers-theo...
The entire theory of Alzheimer's is not resting on that research. Nobody believes in amyloids exclusively because of it.
[0] https://www.theguardian.com/society/2023/may/03/new-alzheime...
Though the one announced in 2021 made the headlines and appeared to be more of a success than it was. You could say a new drug being approved after 20 years is still a relative success (it does have some statistically significant results which led it to being approved).
But any researcher whose life's work has been tackling the plaque isn't going to like that.
I will profess that the plaque is actually protective and not just "a symptom".
That is why this man had no issues even though he had so many plaques.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166788/
https://www.frontiersin.org/articles/10.3389/fncel.2020.0028...
Is Reelin commercially available?
Zinc might increase reelin activity though.
https://pubmed.ncbi.nlm.nih.gov/10192793/
It might be that high reelin is protecting but I cannot tell from this study yet what the mutation does.
ADDING:
Found it. It is a GAIN OF FUNCTION mutation, which means more Reelin will help curb Alzheimer's. And to me that means more zinc will help as well.
https://www.nature.com/articles/s41591-023-02318-3
RELN-COLBOS is a gain-of-function variant showing stronger ability to activate its canonical protein target Dab1 and reduce human Tau phosphorylation in a knockin mouse. A genetic variant in a case protected from ADAD suggests a role for RELN signaling in resilience to dementia.
https://pubmed.ncbi.nlm.nih.gov/28209901/
(yes, in mice! but now in clinical trials for glaucoma and looking good. And yes, glaucoma is not AD, but many/most forms of neurodegenerations are associated with high mitochondrial stress/dysfunction).
It is not complex, it is simple. I believe it is a metabolic disease caused by metabolic disease and genetic risk. That will be unique for everyone, but for most people I feel the answer will be poor zinc handling.
And Niacin is all you can come up with? Did you know we make niacin if we have enough B6 and B2?
https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Term=564...